Equity Overview
Price & Market Data
Price: $3.11
Daily Change: -$0.117 / 3.77%
Daily Range: $3.04 - $3.28
Market Cap: $41,592,968
Daily Volume: 50,017
Performance Metrics
1 Week: 14.98%
1 Month: -2.20%
3 Months: 24.80%
6 Months: 9.25%
1 Year: -74.84%
YTD: -64.71%
Company Details
Employees: 46
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3 kinase alpha harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company is headquartered in Boulder, Colorado.